SPL responds to US FDA warning letter SPL responds to US FDA warning letter 07-Feb-2011 By Gareth Macdonald US Heparin maker Scientific Protein Laboratories (SPL) says it has resolved “many of the issues” addressed in the US Food and Drug Administration (FDA) warning letter it received late last month.